Condition
Paresthesia (numbness, tingling) secondary to chemotherapy-induced neuropathy.
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Oxygen Placebo
Research Leaders
9 sponsors active, led by Bernardino Clavo, MD, PhD
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 2/3 (1)
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Oxygen Placebo1
Active Sponsors
- Bernardino Clavo, MD, PhD1
- Servicio Canario de Salud1
- University of Las Palmas de Gran Canaria1
- Centers for International Business Education and Research1
- Instituto de Salud Carlos III1
Top Investigators
Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain
University of Las Palmas de Gran Canaria
Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain
Related Conditions
- Paresthesia1
- Chemotherapy Induced Peripheral Neuropathy Cipn1
- Numbness1
- Tingling1